Retraction
Worsening of Pre-Existing Valvulopathy With A New Obesity Drug Lorcaserin, A Selective 5-Hydroxytryptamine 2C Receptor Agonist: A Meta-Analysis of Randomized Controlled Trials
Paper Information
Record ID:
17125
Publication Date:
March 07, 2013
Retraction Date:
November 04, 2013
(12.0 years years ago)
Subjects:
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Not indexed in PubMed
Retraction PubMed ID:
Not indexed in PubMed
Retraction Details
Citations (2)
2
Total Citations1
Post-Retraction(50.0%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
275
Days since retraction (latest)
Paper citing Worsening of Pre-Existing Valvulopathy With A New ...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Worsening of Pre-Existing Valvulopathy With A New ...
Unknown Authors
Unknown Journal
Published: Aug 2014
275 days after retraction
Quick Stats
Total Citations:
2
Years Since Retraction:
12.0 years
Open Access:
Yes
Last Checked:
Never